You are here:

standardised allergen extract of grass pollen from Timothy (Phleum pratense) 75,000 SQ-T per oral lyophilisate

Advice

Following a resubmission.

Standardised allergen extract of grass pollen 75,000 SQ-T per oral lyophilisate (Grazax®) is not recommended for use within NHS Scotland for the treatment of grass pollen induced rhinitis and conjunctivitis in adult patients with clinically relevant symptoms and diagnosed with a positive skin prick test and/or specific IgE test to grass pollen.

Although modest clinical benefit has been shown, the manufacturer did not present a sufficiently robust economic analysis to gain acceptance by SMC.

Drug Details

Drug Name: standardised allergen extract of grass pollen from Timothy (Phleum pratense) 75,000 SQ-T per oral lyophilisate
SMC Drug ID: 367/07
Manufacturer: ALK-Abello Ltd
Indication: Grass pollen induced rhinitis and conjunctivitis in adult patients
BNF Category:
Sub Category: 3.4 Antihistamines*** hyposensitisation*** and allergic emergencies
Submission Type: Resubmission
Status: Not Recommended
Date Advice Published: 14 January 2008

Archived Advice

Full submission 7 May 2007

Back